Your Client Rank:
Loading...
99
Updated 02-Oct-2022
| Company | Sales | Gross M. | SGA % Sales | R&D % Sales | Trading M. | Tax Rate | Net Income | EPS |
| | | | | | | | |
| Novo | 13.8% | 0.3% | -1.9% | 1.4% | 1.5% | 1.6% | 14.9% | 16.5% |
| Daiichi | 13.4% | 3.9% | 0.5% | -5.5% | 29.9% | 22.2% | 41.2% | 42.1% |
| Lilly | 9.6% | 1.0% | -4.3% | -3.8% | 7.7% | 1.4% | 17.4% | 17.9% |
| Astra | 8.9% | 1.7% | -4.0% | -1.5% | 10.7% | 4.0% | 17.5% | 15.8% |
| Vertex | 8.7% | 0.3% | -0.4% | 1.8% | -0.5% | 0.9% | 8.3% | 8.0% |
| Lundbeck | 7.0% | 1.0% | -3.3% | -4.7% | 14.9% | 6.3% | 17.3% | 17.6% |
| Astellas | 6.7% | 0.4% | -2.0% | -1.6% | 7.0% | -1.2% | 14.5% | 15.7% |
| Sanofi | 6.6% | 1.1% | -3.8% | -0.8% | 5.5% | -1.6% | 11.1% | 11.2% |
| Merck | 5.9% | 0.7% | -2.5% | -4.7% | 5.3% | 3.0% | 11.9% | 12.5% |
| Shionogi | 4.6% | -0.3% | -2.6% | -6.1% | 3.7% | 18.1% | 6.6% | 7.0% |
| Bayer | 3.9% | 0.2% | -3.2% | 1.2% | 6.9% | -14.4% | 7.3% | 7.3% |
| Roche | 3.5% | 0.9% | -0.7% | 0.1% | 1.6% | 4.5% | 4.9% | 6.0% |
| Eisai | 3.2% | 0.5% | 1.4% | -3.0% | 4.1% | 13.7% | 3.0% | 3.0% |
| Amgen | 2.4% | -0.1% | -0.7% | 0.1% | 0.1% | 2.2% | 2.5% | 5.0% |
| Chugai | 2.3% | 1.2% | -0.2% | 0.0% | 1.3% | -1.5% | 3.9% | 3.9% |
| JnJ | 1.9% | 0.0% | -1.2% | -1.0% | 1.6% | 3.2% | 3.0% | 3.7% |
| Novartis | 1.6% | 0.2% | -1.5% | 0.4% | 1.6% | 1.7% | 2.3% | 4.0% |
| Takeda | 1.2% | 0.3% | -0.5% | 1.7% | 4.9% | 2.3% | 11.3% | 11.7% |
| Bristol | 1.1% | -0.9% | -0.6% | -0.2% | -0.4% | 1.0% | 0.9% | 3.2% |
| Teva | 0.7% | 0.4% | 0.1% | 0.2% | 1.1% | 2.0% | 3.7% | 3.2% |
| AbbVie | 0.6% | -0.2% | 1.0% | -1.9% | 0.3% | 1.8% | 1.4% | 1.5% |
| Glaxo | -0.1% | 1.5% | -2.6% | 4.1% | 4.5% | -1.0% | 6.5% | 10.6% |
| Gilead | -1.8% | 0.5% | 2.8% | 1.4% | -1.0% | 0.2% | -2.1% | -1.6% |
| Viatris | -2.3% | 0.1% | -1.3% | 10.0% | -0.4% | -1.5% | -1.9% | -2.1% |
| Biogen | -2.6% | 0.2% | -0.3% | -0.2% | 1.3% | 1.8% | -3.5% | -1.9% |
| Regeneron | -3.9% | 0.6% | 8.6% | 11.5% | -5.6% | 0.5% | -9.3% | -9.9% |
| Pfizer | -4.1% | 4.4% | 3.7% | 5.5% | 4.1% | 0.5% | 0.1% | 0.0% |
| EU Major | 4.8% | 1.0% | -2.5% | 0.3% | 4.3% | 1.5% | 8.4% | 8.6% |
| Other EU | 7.0% | 1.0% | -3.3% | -4.7% | 14.9% | 6.3% | 17.3% | 17.6% |
| US Major | 1.7% | 1.0% | -0.3% | -0.4% | 2.6% | 1.5% | 4.3% | 7.0% |
| US Big Biotech | 0.1% | 0.3% | 1.2% | 2.5% | -1.1% | 1.3% | -1.0% | -3.6% |
| Other US | -0.8% | 0.2% | -0.6% | 4.6% | 0.2% | 0.1% | 0.4% | 0.2% |
| Japanese | 4.5% | 1.1% | 0.2% | -0.9% | 6.6% | 2.0% | 12.5% | 9.8% |
